LAKE FOREST, Calif. & INDIANAPOLIS--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the ...
MIAMI – The pandemic has brought a significant increase in vision complaints, partly fueled during the pandemic as people spent more time than ever staring at screens. The surge in nearsightedness, or ...
LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, is today ...
All right, let's take *** look panel. Robinson has used corrective lenses since first grade. Now working as *** cinematographer and director. His contacts had become *** constant misery. The ...
The pandemic has brought a significant increase in vision complaints, partly fueled during the pandemic as people spent more time than ever staring at screens. The surge in nearsightedness, or myopia, ...
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today ...
Years after initially setting its sights on FDA approval for the latest version of its implanted vision-correcting lens, Staar Surgical has finally reached the regulatory milestone. The Evo/Evo+ ...
In March 2022, the U.S. Food and Drug Administration (FDA) granted approval of the EVO/EVO+ Visian Implantable Collamer Lens (EVO) for the correction of myopia and myopia with astigmatism. Myopia is ...
The first patient has been implanted in an investigational clinical study of STAAR Surgical’s EVO ICL family of lenses, according to a press release. EVO Visian IOLs are designed to treat a wide range ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results